このエントリーをはてなブックマークに追加
ID 54512
JaLCDOI
フルテキストURL
Thumnail 70_4_317.pdf 1.88 MB
著者
Sakurai, Jun Center for Innovative Clinical Medicine, Okayama University Hospital
Matsui, Yusuke Department of Radiology, Okayama University Hospital
Hiraki, Takao Department of Radiology, Okayama University Hospital
Iguchi, Toshihiro Department of Radiology, Okayama University Hospital
Fujiwara, Hiroyasu Department of Radiology, Okayama University Hospital
Gobara, Hideo Department of Radiology, Okayama University Hospital
Mitsuhashi, Toshiharu Center for Innovative Clinical Medicine, Okayama University Hospital
Nagasaka, Takeshi Department of Gastroenterological Surgery Transplant and Surgical Oncology, Okayama University Hospital
Susumu Kanazawa, Susumu Kanazawa Department of Radiology, Okayama University Hospital Kaken ID
抄録
The present single center prospective phase II clinical trial is designed to evaluate the efficacy and safety of percutaneous radiofrequency (RF) ablation for colorectal lung metastases. Patients who have colorectal lung metastases without extrapulmonary metastases are included in this study. The primary endpoint is 3-year overall survival (OS) after RF ablation. The secondary endpoints are the prevalence of adverse events within 4 weeks, local tumor progression rate, 1- and 5-year OS, cause-specific survival, and relapse-free survival. The recruitment of patients commenced in July 2014, and the enrolment of 45 patients is intended over the 3 years of study period.
キーワード
radiofrequency ablation
colorectal cancer
lung metastasis
Amo Type
Clinical Study Protocols
発行日
2016-08
出版物タイトル
Acta Medica Okayama
70巻
4号
出版者
Okayama University Medical School
開始ページ
317
終了ページ
321
ISSN
0386-300X
NCID
AA00508441
資料タイプ
学術雑誌論文
言語
English
著作権者
CopyrightⒸ 2016 by Okayama University Medical School
論文のバージョン
publisher
査読
有り
PubMed ID
Web of Science KeyUT